Of these 15 AML patients one patient has a TP53-mutated AML (7%) without any known malignancies in his family and two patients have a RUNX1-mutated AML (14%) of which one patient has a second grade family member with a lymphoma. This evidence concerns the gene TP53 and lymphoma.